Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +751.11%
#3 ADO Protocol ADO Protocol +101.14%
#4 Cortex Cortex +92.99%
#5 Ontology Gas Ontology Gas +77.68%
#6 Kinesis Silver Kinesis Silver +54.16%
#7 OpenEden OpenEden +35.10%
#8 Biconomy Biconomy +28.11%
#9 Magma Finance Magma Finance +26.20%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Viking Therapeutics, Inc. Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

VKTX
Pozycja w akcjach #4213
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Cena akcji
$34.45
Kapitalizacja rynkowa
$4.02B
Zmiana (1 dzień)
0.83%
Zmiana (1 rok)
32.31%
Kraj
US
Handel Viking Therapeutics, Inc. (VKTX)

Kategoria

Healthcare
Historia ceny akcji dla Viking Therapeutics, Inc. (VKTX)
Najwyższa cena zamknięcia: $33.94 dnia 2026-08-01

Najniższa cena zamknięcia: $8.59 dnia 2015-04-01
Historia cen akcji firmy Viking Therapeutics, Inc. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -9.08%
2025 -20.83%
2024 152.59%
2023 215.71%
2022 16.84%
2021 -21.08%
2020 -20.48%
2019 -10.51%
2018 130.53%
2017 246.93%
2016 -60.36%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.84 42.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.13%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $147.64 496.99%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 6.25%
CH